Zanzalintinib in Men With Aggressive Variant Prostate Cancer
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
Recruiting · NCT07218666 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanzalintinib in Men With Aggressive Variant Prostate Cancer | Aggressive Variant Prostate Carcinoma | Recruiting | Phase 2 | 2026-08-28 | NCT07218666 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Deepak Kilari | 2 |
| Exelixis | 77 |
| Medical College of Wisconsin | 201 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Froedtert and The Medical College of Wisconsin | Milwaukee | United States | 21 |